Share Issuance Through the Exercise of Stock Acquisition Rights
First written in FY2017-Q2. 11 of 20 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2027-H1.
21 other companies' latest entry also says "Other".
- FY2027-H1Share issuances from exercises of share acquisition rights through the filing date not reflectedAnnual report
「The number of shares issued as of the filing date does not include shares issued through the exercise of share acquisition rights from 1 November 2026 through the filing date of this interim report.」
Although there was no increase in the total number of issued shares during the interim consolidated accounting period, the Company stated that shares issued through the exercise of share acquisition rights from 1 November 2026 through the filing date were not reflected in the number of shares issued as of the filing date. - FY2024No proceeds from the exercise of share acquisition rightsAnnual report
「Proceeds from the issuance of shares upon the exercise of share acquisition rights 11,495 -」
The ¥11.495 million in proceeds from the issuance of shares upon the exercise of share acquisition rights recorded in the previous fiscal year was not recorded in the current fiscal year. - FY2024-Q3Share issuances from exercises of share acquisition rights through the filing date not reflectedAnnual report
「The number of shares issued as of the filing date does not include shares issued upon the exercise of share acquisition rights between 1 February 2024 and the filing date of this quarterly report.」
The company stated that shares issued upon the exercise of share acquisition rights between 1 February 2024 and the filing date were not reflected in the number of shares issued at the end of the quarterly accounting period. - FY2024-Q1Share issuances from exercises of share acquisition rights through the filing date not reflectedAnnual report
「The number of shares issued as of the filing date does not include shares issued upon the exercise of share acquisition rights between 1 August 2023 and the filing date of this quarterly report.」
Although there was no increase in the number of shares during the current quarter, shares were issued upon the exercise of share acquisition rights between 1 August 2023 and the filing date, and those shares were not reflected in the number of shares issued as of the filing date. - FY2023AdvancedAnnual report
「Cash used in financing activities was ¥35.995 million. The main components were ¥47.454 million in dividends paid and ¥11.495 million in proceeds from the issuance of shares upon the exercise of share acquisition rights.」
The company recorded ¥11.495 million in proceeds from the issuance of shares upon the exercise of share acquisition rights. - FY2023-Q2DroppedAnnual report
「② Status of Other Stock Acquisition Rights, etc. Not applicable.」
The company stated that there were no applicable matters concerning the status of other share acquisition rights and similar instruments during the cumulative second quarter ended to date. - FY2022RestatedAnnual report
「Cash used in financing activities was ¥36.244 million. The main components were ¥42.439 million in dividends paid and ¥6.195 million in proceeds from the issuance of shares upon the exercise of share acquisition rights.」
The company also recorded proceeds from the issuance of shares upon the exercise of share acquisition rights during the current period. - FY2022-Q2AdvancedAnnual report
「Cash used in financing activities was ¥36.115 million. The main components were ¥42.310 million in dividends paid and ¥6.195 million in proceeds from the issuance of shares upon the exercise of share acquisition rights.」
During the cumulative second quarter ended to date, the company recorded ¥6.195 million in proceeds from the issuance of shares upon the exercise of share acquisition rights. - FY2022-Q1AdvancedAnnual report
「1 April 2021–30 June 2021 59,000 23,748,800 3,687 78,512 3,687 44,030 (Note) The increase resulted from the exercise of share acquisition rights (stock options).」
During the cumulative first quarter ended to date, the exercise of share acquisition rights increased the number of shares by 59,000 and increased both share capital and the capital surplus by ¥3.687 million. - FY2021AdvancedAnnual report
「1 April 2020–31 March 2021 (Note 1) 247,000 23,689,800 17,826 74,825 17,826 40,343 (Note) 1. Increase resulting from the exercise of share acquisition rights」
During the current fiscal year, the exercise of share acquisition rights increased the number of shares by 247,000, bringing the total number of shares issued to 23,689,800, while share capital and the capital surplus each increased by ¥17.826 million. - FY2021-Q2AdvancedAnnual report
「Cash used in financing activities was ¥13.176 million, compared with an outflow of ¥32.584 million in the same quarter of the previous year. The main components were ¥37.155 million in dividends paid and ¥23.978 million in proceeds from the issuance of shares upon the exercise of share acquisition rights.」
The company recorded ¥23.978 million in proceeds from the issuance of shares upon the exercise of share acquisition rights. During the second quarter, the number of shares increased by 94,500 and both share capital and the capital surplus increased by ¥7.151 million. - FY2021-Q1AdvancedAnnual report
「1 April 2020–30 June 2020 (Note) 152,500 23,595,300 10,675 67,673 10,675 33,192 (Note) The increase resulted from the exercise of share acquisition rights (stock options).」
During the cumulative first quarter ended to date, the exercise of share acquisition rights increased the number of shares by 152,500 and increased both share capital and the capital surplus by ¥10.675 million. - FY2020AdvancedAnnual report
「Proceeds from the issuance of shares upon the exercise of share acquisition rights ¥1.860 million」
During the current consolidated fiscal year, shares were issued upon the exercise of share acquisition rights, resulting in ¥1.860 million in proceeds from financing activities. - FY2020-Q2DroppedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
During the cumulative second quarter ended to date, there was no disclosure of the issuance or exercise of other share acquisition rights, and there was no change in the total number of shares issued. - FY2019-Q2AdvancedAnnual report
「Proceeds from the issuance of shares upon the exercise of share acquisition rights 545」
During the cumulative second quarter ended to date, the company generated ¥545 thousand from the issuance of shares upon the exercise of share acquisition rights. - FY2019-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of share acquisition rights on 25 June 2018 increased the total number of shares issued by 5,000 and increased both share capital and the capital surplus by ¥462 thousand. - FY2018AdvancedAnnual report
「Cash used in financing activities was ¥21.462 million, compared with proceeds of ¥354 thousand in the previous consolidated fiscal year. The main components were ¥23.206 million in dividends paid and ¥1.744 million in proceeds from the issuance of shares upon the exercise of share acquisition rights.」
Proceeds from the issuance of shares upon the exercise of share acquisition rights increased from ¥354 thousand in the previous fiscal year to ¥1.744 million, while dividend payments resulted in an overall cash outflow from financing activities. - FY2018-Q3AdvancedAnnual report
「Between 1 January 2018 and 31 January 2018, the exercise of share acquisition rights (stock options) increased the total number of shares issued by 15,000 and increased both share capital and the capital surplus by ¥1.387 million.」
The exercise of share acquisition rights after the end of the quarter increased the total number of shares issued by 15,000 and increased both share capital and the capital surplus by ¥1.387 million. - FY2017RestatedAnnual report
「The increase of 17,700 common shares resulted from the issuance of new shares upon the exercise of share acquisition rights.」
The company disclosed the issuance of 17,700 new shares upon the exercise of share acquisition rights and the resulting ¥354 thousand cash inflow for the full fiscal year as well. - FY2017-Q2First statedAnnual report
「Cash generated by financing activities was ¥354 thousand, compared with proceeds of ¥4.492 million in the same quarter of the previous year. The main component was ¥354 thousand in proceeds from the issuance of shares upon the exercise of share acquisition rights.」
The company generated ¥354 thousand from the issuance of shares upon the exercise of share acquisition rights.